Maxcyte ATX electroporation transfection system

This is a Notice of Intent, not a request for proposal. The National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) intends to negotiate on an other than full and open competition basis with MaxCyte Inc. to purchase:

Qty 1 of Catalog#ATX-100 MaxCyte ATX Scalable Transfection System to include clinical and commercial use/software licenses and standard protocols.
Qty 10 of Catalog#SOC4 OC-400 Processing Assemblies, 400 ul volume, lot of 10 units, to include 100mL Electroporation Buffer
Qty 2 of Catalog#SCL1 Processing Assembly CL-1.1 3.5 mL with buffer.

Manufacturer MaxCyte Inc.
To be delivered in 30-45 days.

The statutory authority for this sole source requirement is 41 U.S.C. 1901(e)(2) as implemented by FAR 13.106-1 only one responsible source and no other supply of service will satisfy agency requirements. THIS IS NOT A REQUEST FOR PROPOSAL. All responsible sources that could provide comparable services may submit a capability statement that will be considered by email (subject line to reference NOI-NIAID-1917586) to Janna Weber at janna.weber@nih.gov by 5:00 pm eastern standard time August 2, 2018. All responses received by the closing date of this synopsis will be considered by the Government. A determination not to compete this requirement, based upon responses to this notice, is solely within the discretion of the Government.

.